Jimu news reporter Hu Xiuwen
Recently, the Fujian Provincial Medical Security Bureau released personnel news that Comrade Zhang Jinni's one-year probationary period as the director of the Pharmaceutical equipment procurement supervision department of the Fujian Provincial Medical Security Bureau has expired, and after passing the assessment, he is now officially appointed. The period of appointment is from 28 September 2020.

Who is Jinni Zhang?
She is the negotiator of the National Medical Insurance Bureau who continued to appear on the hot search and brushed the circle of friends in December last year because of the "soul bargaining" in the rare disease drug medical insurance negotiations.
Some time ago, "700,000 shots of sky-high drugs into medical insurance" appeared on the hot search, and Zhang Jinni's bargaining sentence also became popular. "Have you done your best?" "Every small group should not be abandoned."
In the negotiation, the price given by the first round of quotations of the enterprise was 53680 yuan per bottle, and the final transaction price was 33000 yuan. After a long negotiation of one and a half hours, the representatives of the enterprise left the table for eight times, and the transaction price of each bottle of medicine initially quoted by the enterprise was more than 20,000 yuan less than the initial quotation.
What is a sky-high drug?
The "sky-high drug" mentioned above is called Nocinasine sodium injection.
Northinalsan Sodium Injection is the world's first precision-targeted therapeutic drug for spinal muscular atrophy (SMA). On April 28, 2019, Northinalsan Sodium Injection was launched in China and became the first drug in China to treat SMA.
When entering China in 2019, Nocinasin sodium injection was priced at 699,700 yuan per injection, and patients needed to inject 4 injections in the first 63 days and 1 injection every 4 months thereafter, for lifelong medication.
On December 3, 2021, the National Medical Insurance Bureau announced the results of the adjustment of the national medical insurance drug list in 2021, the drug was included in medical insurance, and after secondary reimbursement and policy preferences, the price of each bottle was reduced to less than 17,000 yuan.
The life-saving medicine cut by the "soul bargain" has been launched across the country
On January 1, 2022, this life-saving drug cut by the "soul bargain" was launched nationwide! Children with spinal muscular atrophy in many places have received a wonderful gift in the New Year.
On the 1st, in the First Affiliated Hospital of Fujian Medical University, a 2-year-old child with semi-spinal muscular atrophy from Nanping successfully injected the special drug "Nocinasso" with sodium. The purchase price of the drug per injection was reduced from 700,000 yuan to 33,000 yuan, and the average medical insurance of Fujian patients could also be reimbursed by 60% to 70%, and patients only needed to pay about 10,000 yuan at their own expense.
Ms. Chen, a family member of the child, said that the "sky-high life-saving drug" was expensive and their families could not afford it. This time the medical insurance negotiations came down, and entered the directory with "land price", and they came to receive treatment at the first time.
At about 10:00 a.m. on January 1, at the inpatient department of Henan Provincial Children's Hospital, a dose of Nosinasin sodium injection was smoothly pushed into the body of the child Yiyi (pseudonym). The injection of just two minutes carries a lot of attention, effort and joy.
On the first day of the new year, patients with spinal muscular atrophy (SMA) in 11 provinces and cities across the country received the first batch of injection treatment. Including Yiyi, 6 children in Henan were marked with Nosina raw sodium after "landing".
The promise that "every small group should not be abandoned" is becoming a warm reality.
(Source: People's Daily, Xinhua Net)